Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV000182861 | SCV000235249 | uncertain significance | not provided | 2014-09-03 | criteria provided, single submitter | clinical testing | p.Met393Arg (ATG>AGG): c.1178 T>G in exon 14 of the RYR2 gene (NM_001035.2). A variant of unknown significance has been identified in the RYR2 gene. The M393R variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The M393R variant was not observed in approximately 6,000 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The M393R variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved within mammals. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. A missense mutation in a nearby residue (D400H) has been reported as possibly associated with LQTS. The patient harboring the D400H variant had a nonspecific sudden unexplained death (with no previously established sudden death?predisposing cardiac condition) and a positive family history of sudden cardiac death; however, no segregation studies were performed (Tester et. al., 2012). Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. The variant is found in ARRHYTHMIA panel(s). |